Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 3915-3922

  Gibson, A W ^a   Edberg, J C ^a   Wu, J ^a   Westendorp, R G J ^a   Huizinga, T W J ^a   Kimberly, R P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NUCLEOTIDE;

ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; FAMILY STUDY; GENE SEQUENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE GENETICS; REPORTER GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035869289     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.3915     Document Type: Article

References (55)

1. Interleukin-10: Biology, role in inflammation and autoimmunity
2. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
3. IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity: Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-γ IL-4, and IL-10
4. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein
5. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
6. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity
7. Enforced Bcl2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease
8. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus
9. Anti-inflammatory cytokine profile and mortality in febrile patients
10. Genetic influence on cytokine production and fatal meningococcal disease
11. Interleukin-10 response abnormalities in systemic lupus erythematosus
12. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
13. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-γ-secreting cells in the peripheral blood
14. Interleukin-8, interleukin-10, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression levels are higher in synovial tissue from patients with rheumatoid arthritis than in osteoarthritis
15. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritis
16. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins
17. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane
18. Elevated interleukin-10 levels in patients with rheumatoid arthritis
19. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus: A potential mechanism of B lymphocyte hyperactivity and autoimmunity
20. Isolation of the human interleukin 10 promoter: Characterization of the promoter activity in Burkitt's lymphoma cell lines
21. Mapping of the human IL-10 gene and further characterization of the 5′ flanking sequence
22. The AT-rich region between -54 to -66 is important for the promoter activity of interleukin-10 in Epstein-Barr virus positive Burkitt's lymphoma cells
23. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells
24. A polymorphic dinucleotide repeat in the human IL-10 promoter
25. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL-10 gene
26. An investigation of polymorphism in the interleukin-10 gene promoter
27. Interleukin 10 secretion in relation to human IL-10 locus haplotypes
28. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus
29. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus
30. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility
31. IL-10 polymorphisms in relation to production and rheumatoid arthritis
32. Systemic lupus erythematosus candidate genes in the Italian population: Evidence for a significant association with interleukin-10
33. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis
34. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus
35. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus
36. Determination of tumour necrosis factor-α and interleukin-10 production in a whole blood stimulation system: Assessment of laboratory error and individual variation
37. The 1982 revised criteria for the classification of systemic lupus erythematosus
38. Quantitation of mRNA by the polymerase chain reaction
39. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees
40. Haplotype associated with low interleukin-10 production in patients with severe asthma
41. New polymorphisms in the IL-10 promoter region
42. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
43. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
44. The -308 tumor necrosis factor-α promoter polymorphism effects transcription
45. Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α 238A promoter polymorphism
46. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy
47. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene
48. Posttranscriptional regulation of IL-10 gene expression through sequences in the 3′-untranslated region
49. Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: Identification and characterization of NF-κB binding sites in the regulatory region of the interleukin-10 gene
50. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs
51. Differential regulation of monocytic tumor necrosis factor-α and interleukin-10 expression
52. Role of stat3 in lipopolysaccharide-induced IL-10 gene expression
53. Estrogen enhancement of antidouble-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
54. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families
55. Are differences in IL-10 production associated with joint damage?